Follow on Google News News By Tag Industry News * General * More Industries... News By Location Country(s) Industry News
Follow on Google News | Vedic Lifesciences begins clinical trial for US Dietary SupplementPhase II studies to begin under Vedic Lifesciences for a US Dietary Supplement known to lower blood pressure and improve blood circulation.
By: vedic Redwood Shores, CA, based Vedic Lifesciences which supports ongoing research in this Therapeutic area announced the start of a Phase II Study on LevodynTM by Nathans Natural. Manufactured under the highest standards and with U.S. Pharmaceutical Grade ingredients, LevodynTM is known for its science to lower blood pressure, improve blood circulation, etc. The trial will be a double blind, randomized, placebo-controlled, parallel- group, multicentric study to evaluate the Efficacy and safety of this supplement in subjects with mild hypertension. Vedic has in the past served Nutraceutical companies for clinical trials in the segment of cardiovascular diseases. The Project Management team at Vedic assigned for this study has tremendous experience in setting up and managing multicentric cardiovascular trials. Jayesh Chaudhary, CEO, Vedic Lifesciences, added that he was indeed pleased to welcome Nathans Natural and bring affordable solutions to supplement companies for claim substantiation conforming to FTC requirements. Anthony Durazo, Founder, Nathans Natural commented,” I was convinced about Vedic’s credibility in managing my clinical trials, by looking at the past work which they have managed for US and Canadian Nutraceutical firms. About Vedic Lifesciences Founded in 2000, Vedic Lifesciences is a full service Contract Research Organization (CRO) serving the Nutraceutical industry worldwide. Serving the North American, Canadian and European market from its US office and the Asian subcontinent from India. Vedic Lifesciences has been catering to the research and regulatory needs of the Traditional Herbal Medicine, Chinese Medicine, Natural Health Products, Ayurvedic, Homeopathic and other alternative and complementary medicine industry since the last decade. Clinical Research data from Vedic has been accepted by Regulatory bodies worldwide and Clinical Research Papers published in top of the line peer reviewed journals. Reference: 1. Mathers C, Stevens G, Mascarenhas M. Global health risks: mortality and burden of disease attributable to selected major risks. Geneva, Switzerland: End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|